Earnings History Data for Can-Fite Biopharma Ltd (CANF) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Can-Fite Biopharma Ltd
Can Fite Biopharma Ltd. is a biopharmaceutical company. It is focused on developing drugs for the treatment of cancer and autoimmune inflammatory diseases. The Company's lead drug candidate, CF101, is in clinical development for the treatment of autoimmune inflammatory diseases. Its CF102 drug candidate is being developed for the treatment of liver diseases and its CF602 drug is being developed for the treatment of inflammation and sexual dysfunction. Can Fite Biopharma Ltd. is based in Petach Tikva, Israel.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28-03-2024 | PM | CANF | CanFite Biopharma | 8.00 | -0.31 | -0.27 | 0.00 | Can-Fite Biopharma GAAP EPS of -$0.01, revenue of $0.74M [3/28/2024 7:20 AM] |
2.23 | -0.03 (-1.33%) |
0.0 | 0.0 (0.00%) |
1.52 - 3.33 | 6,852 | 10,000 | 0 | ||
| 30-11-2023 | PM | CANF | CanFite Biopharma | 8.00 | -0.43 | -0.43 | 0.00 | Can-Fite Biopharma GAAP EPS of $0.00 beats by $0.43, revenue of $0.59M beats by $0.39M [11/30/2023 7:08 AM] |
2.35 | 0.03 (1.49%) |
2.22 | -0.10 (-4.12%) |
1.52 - 8.60 | 68,823 | 500,000 | 6,152 | ||
| 27-05-2021 | PM | CANF | Canfite Biopharma Ltd | 35.00 | -0.12 | -0.17 | 0.00 | Can-Fite Biopharma EPS beats by $0.19, misses on revenue [5/27/2021 7:20 AM] |
2.06 | -0.08 (-3.74%) |
2.21 | 0.07 (3.27%) |
1.51 - 4.39 | 528,256 | 130,000 | 3,481 | ||
|
||||||||||||||||||
| 25-03-2021 | PM | CANF | Canfite Biopharma Ltd | 42.00 | -0.30 | -0.13 | 0.00 | Can-Fite Biopharma EPS beats by $1.22, misses on revenue [3/25/2021 8:57 AM] |
2.32 | 0.02 (0.87%) |
2.28 | -0.02 (-0.87%) |
1.15 - 4.39 | 655,172 | 19,370,000 | 92,066 | ||
| 30-11-2020 | PM | 0:00 AM ET (Nov 30) |
CANF | Can-Fite Biopharma Ltd | 28.05 | -0.24 | -0.25 | -0.90 | 1.92 | 0.04 (1.86%) |
1.93 | 0.05 (2.66%) |
1.08 - 4.95 | 2,040,423 | 296,451 | 89,154 | ||
|
|
||||||||||||||||||
| 27-08-2020 | PM | 5:30 PM ET (Aug 27) |
CANF | Can-Fite Biopharma Ltd | 33.60 | -0.30 | -0.28 | -1.20 | Can-Fite Biopharma EPS beats by $0.32, misses on revenue [8/27/2020 7:08 AM] |
2.24 | -0.06 (-2.45%) |
2.18 | -0.12 (-5.22%) |
1.08 - 4.95 | 275,395 | 986,647 | 43,999 | |
|
|
||||||||||||||||||
| 01-06-2020 | PM | 0:00 AM ET (May 29) |
CANF | Can-Fite Biopharma Ltd | 20.10 | -0.72 | -0.36 | -1.20 | 2.05 | -0.10 (-4.65%) |
2.05 | -0.10 (-4.65%) |
1.08 - 4.95 | 454,959 | 1,048,826 | 28,205 | ||
|
|
||||||||||||||||||